search
Back to results

Hysterosalpingo-Foam Ultrasonography Combined With Power Doppler, Compared With Laparoscopy in Tubal Patency Assessment in Cases of Infertility

Primary Purpose

Infertility of Tubal Origin

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Hysterosalpingo-Foam Ultrasonography
Laparoscopy
Sponsored by
Cairo University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Infertility of Tubal Origin

Eligibility Criteria

20 Years - 40 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

Sexually active women in the reproductive age group between 20 and 40 years

  • History of primary or secondary infertility ( either unexplained or suspected tubal factor by history taking )
  • Tubal factor has not been investigated before or has been investigated with inconclusive results

Exclusion Criteria:

  • Age less than 20 or above 40 years.
  • Using contraception.
  • Undiagnosed pregnancy.
  • known allergy to lidocaine.
  • active pelvic inflammatory disease or genital tract bleeding.
  • Patent both tubes as assessed previously ( no need for exposure to further Investigation.

Sites / Locations

  • Kasr Alainy medical school

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Hysterosalpingo-Foam Ultrasonography

laparoscopy

Arm Description

3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging

• Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia

Outcomes

Primary Outcome Measures

Tubal patency
To evaluate the accuracy of Hysterosalpingo-Foam Sonography combined with Power Doppler in assessment of tubal patency in infertile women

Secondary Outcome Measures

Full Information

First Posted
January 13, 2022
Last Updated
January 13, 2022
Sponsor
Cairo University
search

1. Study Identification

Unique Protocol Identification Number
NCT05209542
Brief Title
Hysterosalpingo-Foam Ultrasonography Combined With Power Doppler, Compared With Laparoscopy in Tubal Patency Assessment in Cases of Infertility
Official Title
Hysterosalpingo-Foam Ultrasonography Combined With Power Doppler, Compared With Laparoscopy in Tubal Patency Assessment in Cases of Infertility, (a Cross-sectional Study).
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
February 9, 2018 (Actual)
Primary Completion Date
February 17, 2020 (Actual)
Study Completion Date
April 3, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Cairo University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Women presenting with primary or secondary infertility and are undergoing investigation of tubal patency assessment will be subjected to: The examination is performed between days 5 and 10 of the menstrual cycle. Routine antibiotic prophylaxis using oral Azithromycin the day before and routine administration of NSAID rectal suppository one hour before the procedure Initially, real-time 2D +/- 3D vaginal ultrasound assessment of the pelvis The cervix is to be visualized with a Cusco speculum and to be cleaned with an antiseptic then A No. 5 pediatric Foley catheter will be introduced into the cervical os, using a tenaculum if necessary. The balloon is to be positioned in the lower uterine cavity and to be inflated with 2 ml of saline to prevent backflow of contrast medium through the cervix then the speculum will be removed and the vaginal transducer is going to be reintroduced in the longitudinal plane to confirm correct placement of the catheter. Initial 3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging Power Doppler is very helpful to confirm the direction of the flow as well as the acceleration during injection. Tubal patency and quality of visualization are classified according the following parameters: Flow over the whole length of the tube, fimbrial outflow or peritoneal spillage of contrast provided definite evidence of complete (i.e. proximal and distal) tubal patency. Paracornual flow only without visualization of fimbrial outflow or peritoneal spillage suggests at least proximal patency. Contrast filling of the endometrial cavity without cornual flow suggests possible tubal occlusion. Technical difficulty making tubal evaluation impossible Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia.
Detailed Description
Women in the reproductive age group between 20 and 40 years old presenting with primary or secondary infertility ( either unexplained or suspected tubal factor by history taking ) and are undergoing investigation of tubal patency assessment Each patient in this study will be subjected to: The examination is performed between days 5 and 10 of the menstrual cycle, the patient in gynecological position, preferably with the aid of one assistant. Routine antibiotic prophylaxis using oral Azithromycin the day before and routine administration of NSAID rectal suppository one hour before the procedure Initially, real-time 2D +/- 3D vaginal ultrasound assessment of the pelvic organs is to be performed using Samsung Elite with endovaginal probe of frequency 6-12 MHz The cervix is to be visualized with a Cussco speculum and to be cleaned with an antiseptic then A No. 5 pediatric Foley catheter will be introduced into the cervical os, using a tenaculum if necessary. The balloon is to be positioned in the lower uterine cavity and to be inflated with 2 ml of saline to prevent backflow of contrast medium through the cervix then the speculum will be removed and the vaginal transducer is going to be reintroduced in the longitudinal plane to confirm correct placement of the catheter. The foam contrast agent is created by combining 3-4mL of 2% lidocaine gel 12-13mL of saline and 3mL air. The assistant creates the foam immediately before application, moving the mixture between two connected 20-mL syringes, until a whitish suspension is obtained (approximately 10-20 times). Initial 3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging Power Doppler is very helpful to confirm the direction of the flow as well as the acceleration during injection. Acquisition without Doppler usually takes less than 5 s, while acquisition with power Doppler is longer(approximately 10 s) After dataset acquisition, Images will be stored as 2D still images, 2D clips +/- 3D volumes. the patient is to be discharged and final diagnosis is made based on the real-time observations and, if available, offline analyses of acquired datasets. Tubal patency and quality of visualization are classified according the following parameters: Flow over the whole length of the tube, fimbrial outflow or peritoneal spillage of contrast provided definite evidence of complete (i.e. proximal and distal) tubal patency. Paracornual flow only without visualization of fimbrial outflow or peritoneal spillage suggests at least proximal patency. Contrast filling of the endometrial cavity without cornual flow suggests possible tubal occlusion. Technical difficulty making tubal evaluation impossible e.g. absent filling of the endometrial cavity due to backflow of contrast, inability to introduce the catheter into the cervical os or maintain the catheter in the correct position preventing instillation of contrast into the endometrial cavity. Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia. The raters are to be blinded to the results of the ultrasound examination until endoscopic diagnosis is to be performed Comparison between the results of the above mentioned techniques will be done and statistical analysis of the results will be carried out

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility of Tubal Origin

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
119 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Hysterosalpingo-Foam Ultrasonography
Arm Type
Active Comparator
Arm Description
3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging
Arm Title
laparoscopy
Arm Type
Active Comparator
Arm Description
• Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia
Intervention Type
Procedure
Intervention Name(s)
Hysterosalpingo-Foam Ultrasonography
Intervention Description
Initial 3-5 ml of foam contrast is to be introduced slowly into the endometrial cavity while the flow of contrast medium in each tube is evaluated using grayscale and power Doppler imaging Power Doppler is very helpful to confirm the direction of the flow as well as the acceleration during injection
Intervention Type
Procedure
Intervention Name(s)
Laparoscopy
Intervention Description
• Standard laparoscopic evaluation with the dye test (methylene blue staining) is to be performed 1 day after ultrasound tests with 1 day of hospitalization under general anesthesia
Primary Outcome Measure Information:
Title
Tubal patency
Description
To evaluate the accuracy of Hysterosalpingo-Foam Sonography combined with Power Doppler in assessment of tubal patency in infertile women
Time Frame
During the ultrasound

10. Eligibility

Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Sexually active women in the reproductive age group between 20 and 40 years History of primary or secondary infertility ( either unexplained or suspected tubal factor by history taking ) Tubal factor has not been investigated before or has been investigated with inconclusive results Exclusion Criteria: Age less than 20 or above 40 years. Using contraception. Undiagnosed pregnancy. known allergy to lidocaine. active pelvic inflammatory disease or genital tract bleeding. Patent both tubes as assessed previously ( no need for exposure to further Investigation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ahmed Mohamed Maged M ElGoly
Organizational Affiliation
Cairo University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kasr Alainy medical school
City
Cairo
ZIP/Postal Code
12151
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Hysterosalpingo-Foam Ultrasonography Combined With Power Doppler, Compared With Laparoscopy in Tubal Patency Assessment in Cases of Infertility

We'll reach out to this number within 24 hrs